These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11964016)
21. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy. Losa M; Fortunato M; Molteni L; Peretti E; Mortini P Minerva Endocrinol; 2008 Dec; 33(4):329-40. PubMed ID: 18923369 [TBL] [Abstract][Full Text] [Related]
22. Current concepts and controversies in the management of non-functioning giant pituitary macroadenomas. Agrawal A; Cincu R; Goel A Clin Neurol Neurosurg; 2007 Oct; 109(8):645-50. PubMed ID: 17686573 [TBL] [Abstract][Full Text] [Related]
23. Nonadenomatous tumors of the pituitary and sella turcica. Huang BY; Castillo M Top Magn Reson Imaging; 2005 Jul; 16(4):289-99. PubMed ID: 16785844 [TBL] [Abstract][Full Text] [Related]
24. [Malignant tumors of the female genitalia in childhood--yesterday, today and tomorrow]. Horejsí J; Rob L Cas Lek Cesk; 2003 Feb; 142(2):84-7. PubMed ID: 12698534 [TBL] [Abstract][Full Text] [Related]
25. The expression of ghrelin in somatotroph and other types of pituitary adenomas. Wasko R; Jaskula M; Kotwicka M; Andrusiewicz M; Jankowska A; Liebert W; Sowinski J Neuro Endocrinol Lett; 2008 Dec; 29(6):929-38. PubMed ID: 19112387 [TBL] [Abstract][Full Text] [Related]
26. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha. Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805 [TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095 [TBL] [Abstract][Full Text] [Related]
31. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior. Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800 [TBL] [Abstract][Full Text] [Related]
32. Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Gejman R; Swearingen B; Hedley-Whyte ET Hum Pathol; 2008 May; 39(5):758-66. PubMed ID: 18439942 [TBL] [Abstract][Full Text] [Related]
33. Surgical management of pituitary adenomas. Jane JA; Laws ER Singapore Med J; 2002 Jun; 43(6):318-23. PubMed ID: 12380732 [TBL] [Abstract][Full Text] [Related]
34. The therapy for hypothalamic-pituitary tumors. Styne DM Endocrinol Metab Clin North Am; 1993 Sep; 22(3):631-48. PubMed ID: 8243452 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of pituitary adenomas. Lleva RR; Inzucchi SE Curr Opin Oncol; 2011 Jan; 23(1):53-60. PubMed ID: 21076304 [TBL] [Abstract][Full Text] [Related]
37. [Clinical staging of pituitary tumors--an analysis of treatment results in 205 cases]. Yang TE Zhonghua Zhong Liu Za Zhi; 1984 May; 6(3):199-202. PubMed ID: 6510198 [No Abstract] [Full Text] [Related]